Tracking serious influenza, COVID-19, and other respiratory infections in working-age Indian adults
RFA-IP-22-001 - Burden and sequelae of influenza, SARS-CoV-2 and other respiratory viruses associated Severe Acute Respiratory Infections among Indian adult population aged 18-60yrs
This project follows adults aged 18–60 in India who get severe respiratory infections to find out how often they happen, what long-term problems and costs result, and how well vaccines protect against serious illness.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | All-India Institute of Medical Sciences NIH-funded |
| Lab location | 1 site (New Delhi, India) |
| Project ID | NIH-11137548 on NIH RePORTER |
What this research studies
Researchers at major public hospitals across India will enroll adults hospitalized with severe acute respiratory infections into a common registry and collect respiratory samples to identify the viruses. Enrolled patients will be followed over time to document recovery, any longer-term health effects, and the chance of getting infected again. The project will record treatment costs and ask about vaccine use and hesitancy, then compare outcomes by vaccination status to estimate protection. The network will also train health professionals and share findings with policymakers to improve prevention and care.
Who could benefit from this research
Good fit: Adults aged 18–60 in India who are hospitalized with severe acute respiratory infections or who agree to join follow-up after such an illness are the best candidates.
Not a fit: Children, people over 60, those without respiratory illness, or people living outside participating regions of India are unlikely to be enrolled or directly benefit from this project.
Why it matters
Potential benefit: If successful, this work could guide policies to prevent severe infections, improve vaccine use, and reduce long-term health and economic impacts for working-age adults in India.
How similar studies have performed: Hospital-based surveillance and vaccine-effectiveness efforts — including earlier work at AIIMS — have previously informed public health actions, and this project expands that approach to more sites.
Where this research is happening
New Delhi, India
- All-India Institute of Medical Sciences — New Delhi, India (Active)
Researchers
- Principal investigator: Krishnan, Anand — All-India Institute of Medical Sciences
- Study coordinator: Krishnan, Anand
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.